文献
J-GLOBAL ID:201802245230548602
整理番号:18A0130528
トリプルネガティブ乳癌の治療のための治療標的としての変異体p53:抗p53薬PK11007の前臨床研究【Powered by NICT】
Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007
著者 (12件):
Synnott Naoise C.
(UCD School of Medicine, University College Dublin, Dublin 4, Ireland)
,
Bauer Matthias R.
(Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom)
,
Madden Stephen
(Population Health Sciences, Department of Psychology, Royal College of Surgeons in Ireland, Dublin, Ireland)
,
Murray Alyson
(UCD School of Medicine, University College Dublin, Dublin 4, Ireland)
,
Klinger Rut
(UCD School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin 4, Ireland)
,
O’Donovan Norma
(National Institute for Cellular Biotechnology (NICB), Dublin City University, Dublin, Ireland)
,
O’Connor Darran
(Department of Molecular & Cellular Therapeutics, Royal College of Surgeons Ireland, Dublin, Ireland)
,
Gallagher William M.
(UCD School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin 4, Ireland)
,
Crown John
(Department of Medical Oncology, St Vincent’s University Hospital, Dublin 4, Ireland)
,
Fersht Alan R.
(Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom)
,
Duffy Michael J.
(UCD School of Medicine, University College Dublin, Dublin 4, Ireland)
,
Duffy Michael J.
(UCD Clinical Research Centre, St. Vincent’s University Hospital, Dublin 4, Ireland)
資料名:
Cancer Letters
(Cancer Letters)
巻:
414
ページ:
99-106
発行年:
2018年
JST資料番号:
E0606B
ISSN:
0304-3835
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)